BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18030518)

  • 21. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
    Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
    Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast-conserving surgery after neoadjuvant chemotherapy in patients with locally advanced cancer. Preliminary results.
    Vergine M; Scipioni P; Garritano S; Colangelo M; Di Paolo A; Livadoti G; Maturo A; Monti M
    G Chir; 2013; 34(9-10):254-6. PubMed ID: 24629809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
    Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
    Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological assessment of the response of locally advanced breast cancer to neoadjuvant chemotherapy and its implications for surgical management.
    El-Didi MH; Moneer MM; Khaled HM; Makarem S
    Surg Today; 2000; 30(3):249-54. PubMed ID: 10752778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant induction chemotherapy.
    Schwartz G
    Minerva Ginecol; 2005 Jun; 57(3):327-48. PubMed ID: 16166939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparative Validation of Primary Surgical Versus Post-neo-adjuvant Chemotherapy Sentinel Lymph Node Biopsy for Stage III Breast Cancers.
    Agarwal G; Rajan S; Gambhir S; Lal P; Krishnani N; Kheruka S
    World J Surg; 2016 Jul; 40(7):1583-9. PubMed ID: 26324160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?
    Schaefgen B; Funk A; Sinn HP; Bruckner T; Gomez C; Harcos A; Stieber A; Haller A; Nees J; Togawa R; Pfob A; Hennigs A; Hederer J; Riedel F; Fastner S; Sohn C; Heil J; Golatta M
    Breast Cancer Res Treat; 2022 Feb; 191(3):589-598. PubMed ID: 34878635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of vascular endothelial growth factor and proliferation marker MIB1 are influenced by neoadjuvant chemotherapy in locally advanced breast cancer.
    Singh M; Capocelli KE; Marks JL; Schleicher RB; Finlayson CA; Seligman PA
    Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):147-56. PubMed ID: 15894927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omission of radiotherapy after breast conservation surgery in the postneoadjuvant setting.
    Esposito AC; Crawford J; Sigurdson ER; Handorf EA; Hayes SB; Boraas M; Bleicher RJ
    J Surg Res; 2018 Jan; 221():49-57. PubMed ID: 29229152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant Therapy in Nonmetastatic Breast Cancer in Kurdistan, Iraq.
    Namiq KS; Sulaiman LR
    JCO Glob Oncol; 2023 May; 9():e2200276. PubMed ID: 37216625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
    Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
    Narui K; Ishikawa T; Satake T; Adachi S; Yamada A; Shimada K; Shimizu D; Kida K; Sugae S; Ichikawa Y; Tanabe M; Sasaki T; Endo I
    Eur J Surg Oncol; 2015 Jan; 41(1):94-9. PubMed ID: 25245538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant Chemotherapy for Breast Cancer, Is Practice Changing? A Population-Based Review of Current Surgical Trends.
    Graham PJ; Brar MS; Foster T; McCall M; Bouchard-Fortier A; Temple W; Quan ML
    Ann Surg Oncol; 2015 Oct; 22(10):3376-82. PubMed ID: 26202561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraoperative ultrasonography-guided surgery: An effective modality for breast conservation after neo-adjuvant chemotherapy.
    Tasdöven I; Karadeniz Çakmak G; Emre AU; Engin H; Bahadır B; Bakkal HB; Güllüoğlu MB
    Breast J; 2020 Sep; 26(9):1680-1687. PubMed ID: 33443786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conventional specimen radiography in breast-conserving therapy: a useful tool for intraoperative margin assessment after neoadjuvant therapy?
    Schäfgen B; Haller A; Sinn HP; Feisst M; Gomez C; Stieber A; Nees J; Togawa R; Pfob A; Hennigs A; Hederer J; Riedel F; Fastner S; Heil J; Golatta M
    Breast Cancer Res Treat; 2023 Aug; 201(1):57-66. PubMed ID: 37302085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical treatment of primary breast cancer in the neoadjuvant setting.
    Kümmel S; Holtschmidt J; Loibl S
    Br J Surg; 2014 Jul; 101(8):912-24. PubMed ID: 24838656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
    Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Neoadjuvant Net: a patient- and surgeon-friendly device to facilitate safe breast-conserving surgery in patients who underwent neoadjuvant treatment.
    Taffurelli M; Montroni I; Santini D; Zamagni C; Fiacchi M; Zanotti S; Pellegrini A; Ugolini G
    Breast; 2012 Aug; 21(4):499-502. PubMed ID: 22237294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer.
    Bhattacharyya M; Ryan D; Carpenter R; Vinnicombe S; Gallagher CJ
    Br J Cancer; 2008 Jan; 98(2):289-93. PubMed ID: 18219287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients.
    Shin HC; Han W; Moon HG; Im SA; Moon WK; Park IA; Park SJ; Noh DY
    Ann Surg Oncol; 2013 Aug; 20(8):2582-9. PubMed ID: 23504119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.